NDC 60575-414

Tricode GF

Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride

Tricode GF is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Respa Pharmaceuticals, Inc.. The primary component is Codeine Phosphate; Guaifenesin; Pseudoephedrine Hydrochloride.

• Product ID: 60575-414_ba3af78f-2f38-48c7-94bf-36416da895a5
• NDC: 60575-414
• Product Type: Human Otc Drug
• Proprietary Name: Tricode GF
• Generic Name: Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride
• Dosage Form: Liquid
• Route of Administration: ORAL
• Marketing Start Date: 2011-06-20
• Marketing Category: OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
• Application Number: part341
• Labeler Name: Respa Pharmaceuticals, Inc.
• Substance Name: CODEINE PHOSPHATE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
• Active Ingredient Strength: 8 mg/5mL; mg/5mL; mg/5mL
• DEA Schedule: CV
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 60575-414-16

473 mL in 1 BOTTLE (60575-414-16)

• Marketing Start Date: 2011-06-20
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 60575-414-16 [60575041416]

Tricode GF LIQUID

• Marketing Category: OTC monograph final
• Application Number: part341
• Product Type: HUMAN OTC DRUG
• Billing Unit: ML
• Marketing Start Date: 2011-06-20
• Inactivation Date: 2019-11-13

Drug Details

Active Ingredients

Ingredient	Strength
CODEINE PHOSPHATE	8 mg/5mL

OpenFDA Data

• SPL SET ID: 2f65d1bb-a5cc-44a2-b7ea-bf7d3c92a870
• Manufacturer:
  • Respa Pharmaceuticals, Inc.
• UNII:
  • GSL05Y1MN6
  • 6V9V2RYJ8N
  • 495W7451VQ
• RxNorm Concept Unique ID - RxCUI:
  • 1114110

NDC Crossover Matching brand name "Tricode GF" or generic name "Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride"

NDC	Brand Name	Generic Name
69036-130	LORTUSS	Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride
60575-414	Tricode	Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride